Tennessee § 68-11-269 Comprehensive infection control program - Admission or transfer of patients

Tennessee Statutes

§ 68-11-269 — Comprehensive infection control program - Admission or transfer of patients

Tennessee § 68-11-269

Title68

This text of Tennessee § 68-11-269 (Comprehensive infection control program - Admission or transfer of patients) is published on Counsel Stack Legal Research, covering Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tenn. Code Ann. § 68-11-269 (2026).

Text

(a)Health care facilities, as part of their infection control program, shall perform a local risk assessment for methicillin resistant staphylococcus aureus (MRSA) in the facility. In those facilities where current interventions have not resulted in reduction in MRSA infections, implementation of a comprehensive program to reduce such infections should occur.

(b)A health care facility's comprehensive infection control program may include, but is not limited to:

(1)Implementation of a hand hygiene education and monitoring program;

(2)The use of contact precautions for patients colonized or infected with MRSA;

(3)The effective cleaning of patient care equipment and the patients' environment;

(4)Consideration of use of active surveillance testing for high risk groups identified through

Free access — add to your briefcase to read the full text and ask questions with AI

(a) Health care facilities, as part of their infection control program, shall perform a local risk assessment for methicillin resistant staphylococcus aureus (MRSA) in the facility. In those facilities where current interventions have not resulted in reduction in MRSA infections, implementation of a comprehensive program to reduce such infections should occur. (b) A health care facility's comprehensive infection control program may include, but is not limited to: (1) Implementation of a hand hygiene education and monitoring program; (2) The use of contact precautions for patients colonized or infected with MRSA; (3) The effective cleaning of patient care equipment and the patients' environment; (4) Consideration of use of active surveillance testing for high risk groups identified through a facility's local risk assessment to identify persons colonized with MRSA; (5) Feedback of surveillance data to key stakeholders, including senior facility leadership, physicians, nursing staff and other clinicians; (6) Education of healthcare personnel about epidemiologically significant organisms; and (7) Education of patients and families about prevention of healthcare-associated infections. (c) Hospitals, nursing homes and other health care facilities should communicate MRSA status of patients transferred or admitted to other facilities; however, facilities should not delay the admission or transfer of patients colonized with MRSA.